| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |